SCHEMBL9864970

SCHEMBL9864970

O=C(NCCOCc1ccccc1)N(S)C(=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 6/20 0.52
▸ HTT P42858 1/20 0.52
▸ LMNA P02545 1/20 0.50
▸ ASAH1 Q13510 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.43
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ ACHE P22303 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ HPGD P15428 2/20 0.38
▸ CTSB P07858 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1577945 0.78 SMN1; SMN2 (0.75) SMN1; SMN2HTTLMNAALDH1A1NPC1
SCHEMBL18626198 0.76 SMN1; SMN2 (0.63) SMN1; SMN2HTTLMNAASAH1ALDH1A1
SCHEMBL4769824 0.76 SMN1; SMN2 (0.67) SMN1; SMN2HTTLMNAASAH1ALDH1A1
SCHEMBL9303009 0.75 ACHE (0.64) SMN1; SMN2ACHE
SCHEMBL9149301 0.75 SMN1; SMN2 (0.55) SMN1; SMN2HTTLMNAASAH1ALDH1A1
SCHEMBL6681460 0.74 RAB9A (0.46) SMN1; SMN2LMNAALDH1A1NPC1RAB9A
SCHEMBL21548219 0.74 SMN1; SMN2 (0.50) SMN1; SMN2HTTLMNAASAH1ALDH1A1
SCHEMBL8604263 0.73 SMN1; SMN2 (0.63) SMN1; SMN2HTTLMNAASAH1ALDH1A1
SCHEMBL8914641 0.73 SMN1; SMN2 (0.63) SMN1; SMN2HTTLMNAASAH1ALDH1A1
SCHEMBL7332230 0.73 SMN1; SMN2 (0.63) SMN1; SMN2HTTLMNAASAH1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 — — US disclosed
Send feedback